Skip to main content

Published locations for Alirocumab gains indication to reduce cardiovascular risks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alirocumab gains indication to reduce cardiovascular risks

User login

  • Reset your password
  • /content/alirocumab-gains-indication-reduce-cardiovascular-risks
  • /clinicianreviews/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular
  • /familypracticenews/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular
  • /fedprac/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular-risks
  • /internalmedicinenews/article/199729/lipid-disorders/alirocumab-gains-indication-reduce
  • /vascularspecialistonline/article/199729/lipid-disorders/alirocumab-gains-indication-reduce
  • /clinicalendocrinologynews/article/199729/lipid-disorders/alirocumab-gains-indication-reduce
  • /ecardiologynews/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular
  • /cardiology/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular-risks
  • /endocrinology/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular-risks
  • /internalmedicine/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular
  • /familymedicine/article/199729/lipid-disorders/alirocumab-gains-indication-reduce-cardiovascular